Is dietary supplementation more common among adults with psoriasis? Results from the national health and nutrition examination survey

Complementary Therapies in Medicine

Volumn 22, Issue 1, 2014, Pages 159-165

  Wilson, Patrick B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PLANT EXTRACTS; PSORIASIS; VITAMINS; YOUNG ADULT;

EID: 84894240215     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.12.007     Document Type: Article

References (37)

1. Rapp S.R., Feldman S.R., Exum M.L., Fleischer Jr A.B., Reboussin D.M. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999, 41:401-407.
2. Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001, 137:280-284.
3. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996, 14:485-496.
4. Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004, 9:136-139.
5. Bickers D.R., Lim H.W., Margolis D., Weinstock M.A., Goodman C., Faulkner E., et al. The burden of skin diseases, 2004, a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006, 55:490-500.
6. Beyer V., Wolverton S. Recent trends in psoriasis systemic treatment costs. Arch Dermatol 2010, 146:46-54.
7. Pariser D.M., Bagel J., Gelfand J.M., Korman N.J., Ritchlin C.T., Strober B.E., et al. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 2007, 143:239-242.
8. U.S.Food and Drug Administration U.S. Department of Health and Human Services. Dietary supplements - Q & A 2013, http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/ucm191930.htm [accessed 18.03.13].
9. Bailey R.L., Gahche J.J., Lentino C.V., Dwyer J.T., Engel J.S., Thomas P.R., et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011, 141:261-266.
10. Bittiner S.B., Cartwright I., Tucker W.F.G., Bleehen S.S. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988, 331:378-380.
11. Maurice P.D., Allen B.R., Barkley A.S., Cockbill S.R., Stammers J., Bather P.C. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987, 117:599-606.
12. Kharaeva Z., Gostova E., De Luca C., Raskovic D., Korkina L. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition 2009, 25:295-302.
13. Rosmarin D.M., Lebwohl M., Elewski B.E., Gottlieb A.B. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2010, 62:838-853.
14. Holden W., Joseph J. Interactions between herbal remedies and antirheumatic drugs. Expert Opin Drug Saf 2005, 4:969-974.
15. Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990, 70:421-424.
16. Clark C.M., Mckay R.A., Fortune D.G., Griffiths C.E. Use of alternative treatments by patients with psoriasis. Br J Gen Pract 1998, 48:1873-1874.
17. Fleischer A.B., Feldman S.R., Rapp S.R., Reboussin D.M., Exum M.L., Clark A.R. Alternative therapies commonly used within a population of patients with psoriasis. Cutis 1996, 58:216-220.
18. Ben-Arye E., Ziv M., Frenkel M., Lavi I., Rosenman D. Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology 2003, 207:302-307.
19. Baron S.E., Goodwin R.G., Nicolau N., Blackford S., Goulden V. Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol 2005, 52:589-594.
20. Smith N., Shin D.B., Brauer J.A., Mao J., Gelfand J.M. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol 2009, 60:419-425.
21. Kalaaji A.N., Wahner-Roedler D.L., Sood A., Chon T.Y., Loehrer L.L., Cha S.S., et al. Use of complementary and alternative medicine by patients seen at the dermatology department of a tertiary care center. Complement Ther Clin Pract 2012, 18:49-53.
22. Kim G.W., Park J.M., Chin H.W., Ko H.C., Kim M.B., Kim J.Y., et al. Comparative analysis of the use of complementary and alternative medicine by Korean patients with androgenetic alopecia, atopic dermatitis and psoriasis. J Eur Acad Dermatol Venereol 2012, 10.1111/j.1468-3083.2012.04583.x.
23. Bruno J.J., Ellis J.J. Herbal use among US elderly: 2002 national health interview survey. Ann Pharmacother 2005, 39:643-648.
24. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005, 27:1847-1858.
25. Smith N., Weymann A., Tausk F.A., Gelfand J.M. Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. J Am Acad Dermatol 2009, 61:841-856.
26. Vlachopoulos C., Terentes-Printzios D., Richter D., Aznaouridis K., Ioakeimidis N., Stefanadis C.I. Omega-3 polyunsaturated fatty acid supplements dose and cardiovascular events: a systematic review and meta-analysis. J Am Coll Cardiol 2013, 61. 10.1016/S0735-1097(13)61421-7.
27. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
28. Ahlehoff O., Gislason G.H., Charlot M., Jorgensen C.H., Lindhardsen J., Olesen J.B., et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011, 270:147-157.
29. Fairris G.M., Lloyd B., Hinks L., Perkins P.J., Clayton B.E. The effect of supplementation with selenium and vitamin E in psoriasis. Ann Clin Biochem 1989, 26:83-88.
30. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
31. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA 2007, 297:842-857.
32. Gorski J.C., Huang S.M., Pinto A., Hamman M.A., Hilligoss J.K., Zaheer N.A., et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004, 75:89-100.
33. Borrelli F., Capasso R., Izzo A.A. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007, 51:1386-1397.
34. Bressler R. Herb-drug interactions: interactions between saw palmetto and prescription medications. Geriatrics 2005, 60:32-34.
35. Chen X.W., Sneed K.B., Pan S.Y., Cao C., Kanwar J.R., Chew H., et al. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 2012, 13:640-651.
36. Martin L.M., Leff M., Calonge N., Garrett C., Nelson D.E. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000, 18:215-218.
37. Kurd S.K., Gelfand J.M. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009, 60:218-224.